(S)-etodolac (BioDeep_00000843846)
代谢物信息卡片
(S)-etodolac
化学式: C17H21NO3 (287.1521356)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
InChI: InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m0/s1
数据库引用编号
5 个数据库交叉引用编号
- ChEBI: CHEBI:60371
- PubChem: 688461
- ChEMBL: CHEMBL1315939
- CAS: 147170-17-0
- CAS: 87249-11-4
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Katsuhito Miyazawa, Yoshitaka Takahashi, Nobuyo Morita, Manabu T Moriyama, Takeo Kosaka, Matomo Nishio, Tanihiro Yoshimoto, Koji Suzuki. Cyclooxygenase 2 and prostaglandin E2 regulate the attachment of calcium oxalate crystals to renal epithelial cells.
International journal of urology : official journal of the Japanese Urological Association.
2012 Oct; 19(10):936-43. doi:
10.1111/j.1442-2042.2012.03060.x. [PMID: 22640700] - Kathryn K Surdyk, Dawn L Sloan, Scott A Brown. Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs.
American journal of veterinary research.
2012 Sep; 73(9):1485-90. doi:
10.2460/ajvr.73.9.1485. [PMID: 22924732] - Jean-Philippe Lafrance, Donald R Miller. Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Jul; 60(1):82-9. doi:
10.1053/j.ajkd.2012.02.328. [PMID: 22503390] - Yukiko Nozawa, Ayako Sato, Hoglan Piao, Tetsuo Morioka, Ichiei Narita, Takashi Oite. The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.
Clinical and experimental nephrology.
2012 Apr; 16(2):221-30. doi:
10.1007/s10157-011-0558-2. [PMID: 22147282] - Jean-Pascal Fournier, Maryse Lapeyre-Mestre, Agnès Sommet, Julie Dupouy, Jean-Christophe Poutrain, Jean-Louis Montastruc. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
PloS one.
2012; 7(3):e34187. doi:
10.1371/journal.pone.0034187. [PMID: 22479557] - Ahmed Abd-Elbary, Mina Ibrahim Tadros, Ahmed Adel Alaa-Eldin. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.
AAPS PharmSciTech.
2011 Jun; 12(2):485-95. doi:
10.1208/s12249-011-9608-z. [PMID: 21479749] - Kazumasa Miki. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - 'ABC method'.
Proceedings of the Japan Academy. Series B, Physical and biological sciences.
2011; 87(7):405-14. doi:
10.2183/pjab.87.405. [PMID: 21785258] - Yuuki Akagi, Yuta Nio, Shuji Shimada, Takao Aoyama. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
Biological & pharmaceutical bulletin.
2011; 34(2):233-7. doi:
10.1248/bpb.34.233. [PMID: 21415533] - Ragia Hegazy, Mohamed Alashhab, Madiha Amin. Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis.
Journal of toxicology.
2011; 2011(?):862153. doi:
10.1155/2011/862153. [PMID: 21776267] - Diana Højmark Omkvist, Birger Brodin, Carsten Uhd Nielsen. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
British journal of pharmacology.
2010 Dec; 161(8):1793-805. doi:
10.1111/j.1476-5381.2010.01000.x. [PMID: 20726987] - Ota Fuchs. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
Current molecular pharmacology.
2010 Nov; 3(3):98-122. doi:
10.2174/1874467211003030098. [PMID: 20594187] - Seung Yoon Lee, Jung Kook Suh, Jin Hwa Choi, Woo Jae Jeon, Mi Ae Cheong. Effect of ketorolac and diclofenac on the impairment of endothelium-dependent relaxation induced by reactive oxygen species in rabbit abdominal aorta.
Korean journal of anesthesiology.
2010 Sep; 59(3):196-202. doi:
10.4097/kjae.2010.59.3.196. [PMID: 20877705] - Yalçin Ozkan, Timurhan Ceyhan, Nuri Arslan, Yavuz Narin, Aşkin Işimer. In-vivo gamma scintigraphic evaluation and determination of a gastro-resistant etodolac tablet in humans.
Combinatorial chemistry & high throughput screening.
2010 Jul; 13(6):490-6. doi:
10.2174/138620710791515833. [PMID: 20426753] - J N King, C Rudaz, L Borer, M Jung, W Seewald, P Lees. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
Research in veterinary science.
2010 Jun; 88(3):497-506. doi:
10.1016/j.rvsc.2009.11.002. [PMID: 20004922] - Kimihiko Yanaoka, Masashi Oka, Noriko Yoshimura, Hisanobu Deguchi, Chizu Mukoubayashi, Shotaro Enomoto, Takao Maekita, Izumi Inoue, Kazuki Ueda, Hirotoshi Utsunomiya, Mikitaka Iguchi, Hideyuki Tamai, Mitsuhiro Fujishiro, Yasushi Nakamura, Tetsuya Tsukamoto, Kenichi Inada, Tatsuya Takeshita, Masao Ichinose. Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
International journal of cancer.
2010 Mar; 126(6):1467-73. doi:
10.1002/ijc.24862. [PMID: 19711347] - Nahla S Barakat. Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation.
The Journal of pharmacy and pharmacology.
2010 Feb; 62(2):173-80. doi:
10.1211/jpp.62.02.0004. [PMID: 20487196] - Jean-Philippe Lafrance, Donald R Miller. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
Pharmacoepidemiology and drug safety.
2009 Oct; 18(10):923-31. doi:
10.1002/pds.1798. [PMID: 19585463] - Lisa H Xie, Qigui Li, Jing Zhang, Peter J Weina. Pharmacokinetics, tissue distribution and mass balance of radiolabeled dihydroartemisinin in male rats.
Malaria journal.
2009 May; 8(?):112. doi:
10.1186/1475-2875-8-112. [PMID: 19470172] - Gonzalo Marañón, William Manley, Patricia Cayado, Cruz García, Mercedes Sánchez de la Muela, Elena Vara. Alterations in the glutathione metabolism could be implicated in the ischemia-induced small intestinal cell damage in horses.
BMC veterinary research.
2009 Mar; 5(?):10. doi:
10.1186/1746-6148-5-10. [PMID: 19296836] - Savita Vyas, Piyush Trivedi, Subhash Chandra Chaturvedi. Dextran-etodolac conjugates: synthesis, in vitro and in vivo evaluation.
Acta poloniae pharmaceutica.
2009 Mar; 66(2):201-6. doi:
NULL. [PMID: 19719056] - Pieter de Heer, Maro H Sandel, Gunther Guertens, Gert de Boeck, Margaretha M Koudijs, J Fred Nagelkerke, Jan M C Junggeburt, Ernst A de Bruijn, Cornelis J H van de Velde, Peter J K Kuppen. Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer.
Cancer chemotherapy and pharmacology.
2008 Oct; 62(5):811-9. doi:
10.1007/s00280-007-0668-4. [PMID: 18247029] - Marjo J Karjalainen, Pertti J Neuvonen, Janne T Backman. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
Basic & clinical pharmacology & toxicology.
2008 Aug; 103(2):157-65. doi:
10.1111/j.1742-7843.2008.00252.x. [PMID: 18816299] - Yin-Xiu Jin, Yi-Hong Tang, Su Zeng. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
Journal of pharmaceutical and biomedical analysis.
2008 Apr; 46(5):953-8. doi:
10.1016/j.jpba.2008.01.038. [PMID: 18329215] - Hyun-Soo Lee, Il-Mo Kang, Heon-Woo Lee, Ji-Hyung Seo, Ju-Hee Ryu, Sang-Jun Choi, Myung-Jae Lee, Seo-Young Jeong, Young-Wuk Cho, Kyung-Tae Lee. Development and validation of a high performance liquid chromatography-tandem mass spectrometry for the determination of etodolac in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2008 Feb; 863(1):158-62. doi:
10.1016/j.jchromb.2007.11.032. [PMID: 18218344] - Imtiyaz A Bhat, Iqbal M Pandit, S Mudassar. Study on Prevalence of lodine Deficiency Disorder and Salt Consumption Patterns in Jammu Region.
Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.
2008 Jan; 33(1):11-4. doi:
10.4103/0970-0218.39236. [PMID: 19966989] - Marlene Lúcio, Helena Ferreira, José L F C Lima, Salette Reis. Use of liposomes as membrane models to evaluate the contribution of drug-membrane interactions to antioxidant properties of etodolac.
Redox report : communications in free radical research.
2008; 13(5):225-36. doi:
10.1179/135100008x308939. [PMID: 18796242] - Bharti Sapra, Subheet Jain, A K Tiwary. Percutaneous permeation enhancement by terpenes: mechanistic view.
The AAPS journal.
2008; 10(1):120-32. doi:
10.1208/s12248-008-9012-0. [PMID: 18446512] - Santosh C Das, Aminu Z Mohammed, Sani U Al-Hassan, Abraham A Otokwula, Uche P Isichei. The triad-iodine deficiency, hyperlipidaemia, high coronary risk- in a 'maternal-neonate' population of rural Africa.
Indian journal of clinical biochemistry : IJCB.
2007 Sep; 22(2):79-83. doi:
10.1007/bf02913319. [PMID: 23105688] - Rentian Feng, Suzanne Lentzsch. Treatment of multiple myeloma with SDX-308.
Drug news & perspectives.
2007 Sep; 20(7):431-5. doi:
10.1358/dnp.2007.20.7.1149631. [PMID: 17992265] - A Lee, M G Cooper, J C Craig, J F Knight, J P Keneally. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function.
The Cochrane database of systematic reviews.
2007 Apr; ?(2):CD002765. doi:
10.1002/14651858.cd002765.pub3. [PMID: 17443518] - Stelio P L Luna, Ana C Basílio, Paulo V M Steagall, Luciana P Machado, Flávia Q Moutinho, Regina K Takahira, Cláudia V S Brandão. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
American journal of veterinary research.
2007 Mar; 68(3):258-64. doi:
10.2460/ajvr.68.3.258. [PMID: 17331014] - J L Davis, M G Papich, A J Morton, J Gayle, A T Blikslager, N B Campbell. Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
Journal of veterinary pharmacology and therapeutics.
2007 Feb; 30(1):43-8. doi:
10.1111/j.1365-2885.2007.00811.x. [PMID: 17217400] - Norio Yokoigawa, Noriko Takeuchi, Munetoyo Toda, Mizue Inoue, Masaki Kaibori, Hidesuke Yanagida, Takaaki Inaba, Hironori Tanaka, Tokuhiro Ogura, Hideho Takada, Tadayoshi Okumura, A-Hon Kwon, Yasuo Kamiyama, Hiroshi Nakada. Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream.
Cancer letters.
2007 Jan; 245(1-2):149-55. doi:
10.1016/j.canlet.2006.01.004. [PMID: 16488536] - Toshiro Sugimoto, Masahiro Aoyama, Katsuhisa Kikuchi, Masayoshi Sakaguchi, Naoko Deji, Takashi Uzu, Yoshihiko Nishio, Atsunori Kashiwagi. Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis.
Internal medicine (Tokyo, Japan).
2007; 46(13):1055-8. doi:
10.2169/internalmedicine.46.0094. [PMID: 17603251] - Michiyuki Hakozaki, Hiroshi Hojo, Shinichi Kikuchi, Masafumi Abe. Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
Oncology reports.
2007 Jan; 17(1):169-73. doi:
. [PMID: 17143495] - Azza A K El-Sheikh, Jeroen J M W van den Heuvel, Jan B Koenderink, Frans G M Russel. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
The Journal of pharmacology and experimental therapeutics.
2007 Jan; 320(1):229-35. doi:
10.1124/jpet.106.110379. [PMID: 17005917] - Audrey Griffin. Case of the month. Chronic hepatitis.
JAAPA : official journal of the American Academy of Physician Assistants.
2006 Nov; 19(11):70. doi:
10.1097/01720610-200611000-00012. [PMID: 17124794] - Weidong Liu, Hideji Nakamura, Tohru Tsujimura, Jidong Cheng, Teruhisa Yamamoto, Yuna Iwamoto, Hiroyasu Imanishi, Soji Shimomura, Tetsuo Yamamoto, Tsutomu Hirasawa, Shuichiro Inagaki, Shuhei Nishiguchi, Toshikazu Hada. Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.
Cancer science.
2006 Aug; 97(8):768-73. doi:
10.1111/j.1349-7006.2006.00237.x. [PMID: 16863510] - Tomohito Inoue, Jeff C Ko, Ronald E Mandsager, Mark E Payton, David S Galloway, Douglas N Lange. Efficacy and safety of preoperative etodolac and butorphanol administration in dogs undergoing ovariohysterectomy.
Journal of the American Animal Hospital Association.
2006 May; 42(3):178-88. doi:
10.5326/0420178. [PMID: 16611929] - Omar M E Abdel-Salam. Anti-inflammatory, antinociceptive, and gastric effects of Hypericum perforatum in rats.
TheScientificWorldJournal.
2005 Aug; 5(?):586-95. doi:
10.1100/tsw.2005.78. [PMID: 16088341] - Eldad Ben-Chetrit, Ruth Fischel, Burkhard Hinz, Micha Levy. The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2.
Rheumatology international.
2005 Jun; 25(5):332-5. doi:
10.1007/s00296-004-0442-4. [PMID: 14963695] - Hanefi Ozbek, Gülçin Saltan Citoğlu, Haluk Dülger, Serdar Uğraş, Betül Sever. Hepatoprotective and anti-inflammatory activities of Ballota glandulosissima.
Journal of ethnopharmacology.
2004 Dec; 95(2-3):143-9. doi:
10.1016/j.jep.2004.06.030. [PMID: 15507327] - Jing-Min Shi, Shun-Guo Lai, Chang-Jiang Xu, Geng-Li Duan, Duan Li. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
Acta pharmacologica Sinica.
2004 Aug; 25(8):996-9. doi:
NULL. [PMID: 15301730] - K Tominaga, K Higuchi, E Sasaki, R Suto, T Watanabe, Y Fujiwara, N Oshitani, T Matsumoto, S Kim, H Iwao, T Arakawa. Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.
Alimentary pharmacology & therapeutics.
2004 Jul; 20 Suppl 1(?):143-50. doi:
10.1111/j.1365-2036.2004.01986.x. [PMID: 15298620] - Joel E Wilson, Naduviladath V Chandrasekharan, Kenneth D Westover, Kendra B Eager, Daniel L Simmons. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs.
American journal of veterinary research.
2004 Jun; 65(6):810-8. doi:
10.2460/ajvr.2004.65.810. [PMID: 15198222] - Hiroki Tanaka, Takashi Abe, Susumu Nishimura, Hajime Sakai, Hirokazu Kimura, Mariko Oki, Masanori Nojima, Masako Taga, Shin-ichiroh Matsumoto, Hiroki Takahashi, Kohzoh Imai. [A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.
2004 Jun; 27(3):171-6. doi:
10.2177/jsci.27.171. [PMID: 15291254] - Michael Hedvat, Anjali Jain, Dennis A Carson, Lorenzo M Leoni, Ganghua Huang, Stuart Holden, Desheng Lu, Maripat Corr, William Fox, David B Agus. Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.
Cancer cell.
2004 Jun; 5(6):565-74. doi:
10.1016/j.ccr.2004.05.014. [PMID: 15193259] - Shiro Koizuka, Shigeru Saito, Hideaki Obata, Masayuki Sasaki, Koichi Nishikawa, Kenichiro Takahashi, Yuji Saito, Fumio Goto. Oral etodolac, a COX-2 inhibitor, reduces postoperative pain immediately after fast-track cardiac surgery.
Journal of anesthesia.
2004; 18(1):9-13. doi:
10.1007/s00540-003-0215-3. [PMID: 14991469] - Luc R Borer, John E Peel, Wolfgang Seewald, Peter Schawalder, David E Spreng. Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis.
American journal of veterinary research.
2003 Nov; 64(11):1429-37. doi:
10.2460/ajvr.2003.64.1429. [PMID: 14620781] - Kazuhiko Yamamoto, Wakashi Kitayama, Ayumi Denda, Ayumu Morisaki, Hiroki Kuniyasu, Tadaaki Kirita. Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide.
Cancer letters.
2003 Sep; 199(2):121-9. doi:
10.1016/s0304-3835(03)00382-3. [PMID: 12969784] - H T Sørensen, S Friis, B Nørgård, L Mellemkjaer, W J Blot, J K McLaughlin, A Ekbom, J A Baron. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.
British journal of cancer.
2003 Jun; 88(11):1687-92. doi:
10.1038/sj.bjc.6600945. [PMID: 12771981] - Franz F Immer, Alexsandra S Immer-Bansi, Nathalie Trachsel, Pascal A Berdat, Verena Eigenmann, Michele Curatolo, Thierry P Carrel. Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial.
The Annals of thoracic surgery.
2003 Feb; 75(2):490-5. doi:
10.1016/s0003-4975(02)04311-4. [PMID: 12607659] - Timothy A Ness, Sheila M Torres, Elizabeth A Kramek, Melissa M Blauvelt. Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration.
Veterinary therapeutics : research in applied veterinary medicine.
2003; 4(4):340-9. doi:
. [PMID: 15136976] - David L Panciera, Spencer A Johnston. Results of thyroid function tests and concentrations of plasma proteins in dogs administered etodolac.
American journal of veterinary research.
2002 Nov; 63(11):1492-5. doi:
10.2460/ajvr.2002.63.1492. [PMID: 12428656] - A Miyajima, K Ito, T Asano, K Seta, A Ueda, M Hayakawa. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?.
The Journal of urology.
2001 Sep; 166(3):1124-9. doi:
. [PMID: 11490310] - F Giuliano, J G Ferraz, R Pereira, G de Nucci, T D Warner. Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation.
European journal of pharmacology.
2001 Aug; 426(1-2):95-103. doi:
10.1016/s0014-2999(01)01207-9. [PMID: 11525777] - D B Strickmann, G Blaschke. Isolation of an unknown metabolite of the non-steroidal anti-inflammatory drug etodolac and its identification as 5-hydroxy etodolac.
Journal of pharmaceutical and biomedical analysis.
2001 Jul; 25(5-6):977-84. doi:
10.1016/s0731-7085(01)00358-2. [PMID: 11377082] - H H Maurer, F X Tauvel, T Kraemer. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
Journal of analytical toxicology.
2001 May; 25(4):237-44. doi:
10.1093/jat/25.4.237. [PMID: 11386636] - S Yılmaz, B Uslu, S A Ozkan. Anodic oxidation of etodolac and its square wave and differential pulse voltammetric determination in pharmaceuticals and human serum.
Talanta.
2001 Apr; 54(2):351-60. doi:
10.1016/s0039-9140(00)00653-6. [PMID: 18968258] - D Riendeau, M D Percival, C Brideau, S Charleson, D Dubé, D Ethier, J P Falgueyret, R W Friesen, R Gordon, G Greig, J Guay, J Mancini, M Ouellet, E Wong, L Xu, S Boyce, D Visco, Y Girard, P Prasit, R Zamboni, I W Rodger, M Gresser, A W Ford-Hutchinson, R N Young, C C Chan. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
The Journal of pharmacology and experimental therapeutics.
2001 Feb; 296(2):558-66. doi:
. [PMID: 11160644]